Magnemax tab. 500mg # 50

Dosage form

Round flat-cylindrical tablets of white or almost white color with beveled and scored.

Structure

1 tablet contains:

active substance: magnesium orotate dihydrate 500 mg

excipients: lactose monohydrate, corn starch, microcrystalline cellulose, povidone K-30, croscarmellose sodium, colloidal silicon dioxide (aerosil), sodium cyclamate, talc, magnesium stearate.

pharmachologic effect

Magnesium preparation.

Magnesium is an essential trace element, it is involved in the implementation of more than 300 enzymatic reactions, regulation of cell permeability and neuromuscular excitability.

It is necessary for the provision of many energy processes, it is involved in the metabolism of proteins, fats, carbohydrates and nucleic acids.

Magnesium has a curariform effect on the endings of cholinergic neurons, with a decrease in acetylcholine release.

Magnesium and calcium interact in part synergistically in the body: however, when competitively inhibiting calcium, magnesium can also affect binding sites as a physiological calcium antagonist".

Pharmacokinetics

Approximately 35-40% of the dose taken is absorbed.

Hypomagnesemia stimulates the absorption of magnesium ions.

The presence of orotic acid salts helps to improve the absorption of magnesium.

Magnesium is excreted by the kidneys, excretion decreases with magnesium deficiency and increases with its excess.

Side effects

From the gastrointestinal tract: unstable stools and diarrhea, which usually go away on their own when the dose of the drug is reduced.

From the immune system: allergic reactions.

Selling features

Available without a prescription

Special conditions

The drug contains lactose monohydrate, so its use is not recommended for patients with hereditary galactosemia, glucose and galactose malabsorption syndrome and lactase deficiency.

Influence on the ability to drive vehicles and mechanisms The drug does not affect the ability to drive vehicles, mechanisms and engage in other activities that require increased concentration of attention and speed of psychomotor reactions.

Indications

Established magnesium deficiency, isolated or associated with other deficiency conditions, accompanied by symptoms such as irritability, minor sleep disturbances, gastrointestinal cramps, increased fatigue, muscle pain and spasms, tingling sensation in the muscles.

If after a month of treatment there is no decrease in these symptoms, continued treatment is impractical.

Contraindications

Hypersensitivity to the components of the drug, urolithiasis, renal dysfunction, predisposition to the formation of calcium-magnesium-ammonium-phosphate stones, liver cirrhosis with ascites.

Children under the age of 18.

The drug contains lactose, so it should not be used in patients with lactose intolerance, lactase deficiency or glucose-galactose malabsorption.

Application during pregnancy and during breastfeeding

It can be used during pregnancy only on the recommendation of a doctor.

Magnesium passes into breast milk.

Avoid using the drug during breastfeeding.

The use of the drug during pregnancy and lactation is possible if the potential benefit to the mother outweighs the potential risk to the fetus and child.

Drug interactions

With the simultaneous administration of magnesium-containing drugs with iron preparations, sodium fluoride and tetracyclines, the absorption of the latter may decrease.

In addition, aminoquinolines, quinidine, penicillamine should not be administered simultaneously with magnesium preparations.

Therefore, these drugs should be taken at intervals of 2-3 hours.

Oral contraceptives, diuretics, muscle relaxants, glucocorticosteroids, insulin, reduce the effect of the drug.

Magnesium should be used with caution if you are taking magnesium.

Name ENG

MAGNEMAX

Clinical and pharmacological group

Magnesium preparation

ATX code

Magnesium orotate

Dosage

500mg

Structure

1 tablet contains: active ingredient: magnesium orotate dihydrate 500 mg

excipients: lactose monohydrate, corn starch, microcrystalline cellulose, povidone K-30, croscarmellose sodium, colloidal silicon dioxide (aerosil), sodium cyclamate, talc, magnesium stearate.

Indications

Established magnesium deficiency, isolated or associated with other deficiency conditions, accompanied by symptoms such as: - increased fatigue

- increased irritability

- tingling sensation in the muscles.

- minor sleep disturbances

- gastrointestinal cramps

- pain and muscle spasms

If after a month of treatment there is no decrease in these symptoms, continued treatment is impractical.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 4 years

Contraindications

Hypersensitivity to drug components

- urolithiasis disease

- impaired renal function

- predisposition to the formation of calcium-magnesium-ammonium-phosphate stones

- cirrhosis of the liver with ascites

- children under 18 years of age.

The drug contains lactose, so it should not be used in patients with lactose intolerance, lactase deficiency or glucose-galactose malabsorption.

INN / Active ingredient

Magnesium orotate

Specifications

Category

Vitamin and mineral complexes

Scope of the drug

Vitamins

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

fifty

Minimum age from

18 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Obolenskoe FP

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Magnesium drug

Anatomical and therapeutic characteristics

A12CC09 Magnesium orotate

Dosage form

Pills

Dosage (volume) of the substance in the preparation

magnesium orotate dihydrate 500 mg

Expiration date in days

1095

Package weight, g

thirty

Mode of application

:

Inside, before meals, with a small amount of liquid.

< br> Prescribe 2 tablets 3 times a day for 7 days, then 1 tablet 2-3 times daily.

The duration of the course of treatment is 4 weeks.

Information on technical characteristics, delivery set, country of manufacture "